pd 98059 has been researched along with Respiratory Distress Syndrome in 3 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jarrar, D | 1 |
Kuebler, JF | 1 |
Rue, LW | 1 |
Matalon, S | 1 |
Wang, P | 1 |
Bland, KI | 1 |
Chaudry, IH | 1 |
Fang, WF | 1 |
Cho, JH | 1 |
He, Q | 1 |
Lin, MC | 1 |
Wu, CC | 1 |
Voelkel, NF | 1 |
Douglas, IS | 1 |
Geiser, T | 1 |
Jarreau, PH | 1 |
Atabai, K | 1 |
Matthay, MA | 1 |
3 other studies available for pd 98059 and Respiratory Distress Syndrome
Article | Year |
---|---|
Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms.
Topics: Animals; Cecum; Chemokine CXCL2; Enzyme Inhibitors; Extravascular Lung Water; Flavonoids; Hemorrhage | 2002 |
Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury.
Topics: Animals; Cytokines; Enzyme Inhibitors; Flavonoids; Lipid A; Lipopolysaccharides; Lung; Macrophages; | 2007 |
Interleukin-1beta augments in vitro alveolar epithelial repair.
Topics: Animals; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Flavonoids; I | 2000 |